Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4ICV9
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 3 |
GO:0006351 | DNA-templated transcription | 7 | 3 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 3 |
GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0009058 | biosynthetic process | 2 | 3 |
GO:0009059 | macromolecule biosynthetic process | 4 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0016070 | RNA metabolic process | 5 | 3 |
GO:0018130 | heterocycle biosynthetic process | 4 | 3 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 3 |
GO:0032774 | RNA biosynthetic process | 5 | 3 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 3 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 3 |
GO:0043170 | macromolecule metabolic process | 3 | 3 |
GO:0044237 | cellular metabolic process | 2 | 3 |
GO:0044238 | primary metabolic process | 2 | 3 |
GO:0044249 | cellular biosynthetic process | 3 | 3 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 3 |
GO:0046483 | heterocycle metabolic process | 3 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:0090304 | nucleic acid metabolic process | 4 | 3 |
GO:0097659 | nucleic acid-templated transcription | 6 | 3 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 3 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 3 |
GO:1901576 | organic substance biosynthetic process | 3 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 112 | 114 | PF00675 | 0.566 |
CLV_NRD_NRD_1 | 136 | 138 | PF00675 | 0.524 |
CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.647 |
CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.531 |
CLV_PCSK_KEX2_1 | 114 | 116 | PF00082 | 0.485 |
CLV_PCSK_KEX2_1 | 136 | 138 | PF00082 | 0.524 |
CLV_PCSK_PC1ET2_1 | 105 | 107 | PF00082 | 0.621 |
CLV_PCSK_PC1ET2_1 | 114 | 116 | PF00082 | 0.490 |
DEG_SPOP_SBC_1 | 5 | 9 | PF00917 | 0.688 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 69 | 75 | PF00134 | 0.489 |
DOC_MAPK_gen_1 | 136 | 142 | PF00069 | 0.481 |
DOC_MAPK_MEF2A_6 | 14 | 23 | PF00069 | 0.567 |
DOC_USP7_MATH_1 | 146 | 150 | PF00917 | 0.550 |
DOC_USP7_MATH_1 | 193 | 197 | PF00917 | 0.692 |
DOC_USP7_MATH_1 | 5 | 9 | PF00917 | 0.688 |
DOC_USP7_MATH_1 | 98 | 102 | PF00917 | 0.595 |
LIG_14-3-3_CanoR_1 | 37 | 47 | PF00244 | 0.582 |
LIG_14-3-3_CterR_2 | 198 | 201 | PF00244 | 0.539 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.643 |
LIG_FHA_2 | 118 | 124 | PF00498 | 0.627 |
LIG_FHA_2 | 192 | 198 | PF00498 | 0.735 |
LIG_FHA_2 | 51 | 57 | PF00498 | 0.503 |
LIG_GBD_Chelix_1 | 15 | 23 | PF00786 | 0.552 |
LIG_Pex14_2 | 156 | 160 | PF04695 | 0.539 |
LIG_SH2_STAP1 | 39 | 43 | PF00017 | 0.453 |
LIG_SH2_STAT3 | 39 | 42 | PF00017 | 0.570 |
LIG_TRAF2_1 | 53 | 56 | PF00917 | 0.578 |
LIG_UBA3_1 | 18 | 25 | PF00899 | 0.516 |
LIG_UBA3_1 | 61 | 69 | PF00899 | 0.491 |
MOD_CK1_1 | 149 | 155 | PF00069 | 0.685 |
MOD_CK1_1 | 167 | 173 | PF00069 | 0.475 |
MOD_CK1_1 | 188 | 194 | PF00069 | 0.683 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.682 |
MOD_CK2_1 | 167 | 173 | PF00069 | 0.680 |
MOD_CK2_1 | 174 | 180 | PF00069 | 0.720 |
MOD_CK2_1 | 50 | 56 | PF00069 | 0.500 |
MOD_CK2_1 | 84 | 90 | PF00069 | 0.568 |
MOD_GlcNHglycan | 150 | 154 | PF01048 | 0.696 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.755 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.722 |
MOD_GlcNHglycan | 32 | 35 | PF01048 | 0.612 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.597 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.700 |
MOD_GSK3_1 | 104 | 111 | PF00069 | 0.624 |
MOD_GSK3_1 | 123 | 130 | PF00069 | 0.536 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.537 |
MOD_GSK3_1 | 193 | 200 | PF00069 | 0.676 |
MOD_N-GLC_1 | 50 | 55 | PF02516 | 0.572 |
MOD_N-GLC_2 | 162 | 164 | PF02516 | 0.470 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.710 |
MOD_NEK2_1 | 108 | 113 | PF00069 | 0.591 |
MOD_NEK2_1 | 127 | 132 | PF00069 | 0.303 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.645 |
MOD_PIKK_1 | 38 | 44 | PF00454 | 0.492 |
MOD_PKA_2 | 173 | 179 | PF00069 | 0.738 |
MOD_PKB_1 | 115 | 123 | PF00069 | 0.627 |
MOD_Plk_1 | 122 | 128 | PF00069 | 0.488 |
MOD_Plk_1 | 182 | 188 | PF00069 | 0.735 |
MOD_Plk_2-3 | 90 | 96 | PF00069 | 0.591 |
MOD_SUMO_rev_2 | 7 | 16 | PF00179 | 0.592 |
TRG_ER_diArg_1 | 112 | 115 | PF00400 | 0.547 |
TRG_ER_diArg_1 | 135 | 137 | PF00400 | 0.484 |
TRG_ER_diArg_1 | 99 | 102 | PF00400 | 0.556 |
TRG_NLS_MonoExtC_3 | 112 | 117 | PF00514 | 0.501 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7E0 | Leptomonas seymouri | 62% | 100% |
A0A0S4JM83 | Bodo saltans | 35% | 100% |
A0A1X0P8N4 | Trypanosomatidae | 47% | 100% |
A0A3Q8IVQ2 | Leishmania donovani | 99% | 70% |
A0A422P2F0 | Trypanosoma rangeli | 45% | 100% |
A4HNN6 | Leishmania braziliensis | 79% | 100% |
D0A2I9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
E9ASE5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
Q4Q250 | Leishmania major | 95% | 100% |
V5DRU1 | Trypanosoma cruzi | 46% | 100% |